News
Recipharm acquires GenIbet to bolster Biologics offering
Global contract development and manufacturing organisation (CDMO), Recipharm, has today announced the acquisition of GenIbet, a Portuguese CDMO, specialising in the manufacture of biological clinical trial material and novel modalities such as viral vectors, RNA and microbiome.
The acquisition forms...
News
Samsung Biologics reaches agreement with Biogen to acquire full ownership of Samsung Bioepis
Samsung Biologics announced that it has reached an agreement with Biogen for the buyout of Biogen’s stake in the Samsung Bioepis joint venture for USD $2.3 billion. The transaction is expected to boost earnings growth of Samsung Biologics on...
News
Nasal Covid-19 Vaccine From Bharat Biotech, A Possibility
Bharat Biotech has been granted permission by India’s drug controller to execute standalone phase 3 clinical trials on the intranasal vaccine for COVID-19. Besides this, the drug regulator has also authorised the Indian biotech giant, which is based in...
News
Recipharm secures vaccine manufacturing deal
Global contract development and manufacturing organization (CDMO), Recipharm, has inked a deal with a top 10 big pharma company to support vaccine manufacturing from its facility in Kaysersberg, France.
The agreement was announced following the successful quality audit and will...
News
Pandemic Far From Over As New Variants Keep Us On The Edge
KEY POINTS
According to the WHO's top official, present conditions are suitable for COVID-19 to mutate more variants, and it is a high presumption for anyone to believe that the pandemic is reaching its end.
In the third week...
News
Global Stake In The Chinese Biotech Companies Is On A Rise
The biotechnology industry in China is coming of age as a major licencing deal has been signed between RemeGen Co Ltd and Seagen Inc, a Seattle-based company. The deal marks the biggest of all between a western company and...
News
Omicron Specific Vaccine Trials Get Rolled Out By Moderna
Moderna, the US biotech firm, has announced that it has initiated clinical trials of a booster that is especially designed to fight out the COVID-19 omicron variant. As per the announcement made by the company, there will be a total...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read